1. Hoosier Oncology Group Randomized Phase II Study of Docetaxel, Vinorelbine, and Estramustine in Combination in Hormone-Refractory Prostate Cancer with Pharmacogenetic Survival Analysis
   Noah M. Hahn et al, 2006, Clinical Cancer Research CrossRef
2. CCNB1 and AURKA are critical genes for prostate cancer progression and castration-resistant prostate cancer resistant to vinblastine
   Xi Chen et al, 2022, Frontiers in Endocrinology CrossRef